• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

公共卫生政策对酒精与全球癌症、肝脏疾病和心血管疾病结局的关联。

Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes.

机构信息

Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Observatorio Multicéntrico de Enfermedades Gastrointestinales, OMEGA, Santiago, Chile.

Observatorio Multicéntrico de Enfermedades Gastrointestinales, OMEGA, Santiago, Chile; Departamento de Ciencias de la Salud, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.

出版信息

J Hepatol. 2024 Mar;80(3):409-418. doi: 10.1016/j.jhep.2023.11.006. Epub 2023 Nov 21.

DOI:10.1016/j.jhep.2023.11.006
PMID:37992972
Abstract

BACKGROUND & AIMS: The long-term impact of alcohol-related public health policies (PHPs) on disease burden is unclear. We aimed to assess the association between alcohol-related PHPs and alcohol-related health consequences.

METHODS

We conducted an ecological multi-national study including 169 countries. We collected data on alcohol-related PHPs from the WHO Global Information System of Alcohol and Health 2010. Data on alcohol-related health consequences between 2010-2019 were obtained from the Global Burden of Disease database. We classified PHPs into five items, including criteria for low, moderate, and strong PHP establishment. We estimated an alcohol preparedness index (API) using multiple correspondence analysis (0 lowest and 100 highest establishment). We estimated an incidence rate ratio (IRR) for outcomes according to API using adjusted multilevel generalized linear models with a Poisson family distribution.

RESULTS

The median API in the 169 countries was 54 [IQR 34.9-76.8]. The API was inversely associated with alcohol use disorder (AUD) prevalence (IRR 0.13; 95% CI 0.03-0.60; p = 0.010), alcohol-associated liver disease (ALD) mortality (IRR 0.14; 95% CI 0.03-0.79; p = 0.025), mortality due to neoplasms (IRR 0.09; 95% CI 0.02-0.40; p = 0.002), alcohol-attributable hepatocellular carcinoma (HCC) (IRR 0.13; 95% CI 0.02-0.65; p = 0.014), and cardiovascular diseases (IRR 0.09; 95% CI 0.02-0.41; p = 0.002). The highest associations were observed in the Americas, Africa, and Europe. These associations became stronger over time, and AUD prevalence was significantly lower after 2 years, while ALD mortality and alcohol-attributable HCC incidence decreased after 4 and 8 years from baseline API assessment, respectively (p <0.05).

CONCLUSIONS

The API is a valuable instrument to quantify the robustness of alcohol-related PHP establishment. Lower AUD prevalence and lower mortality related to ALD, neoplasms, alcohol-attributable HCC, and cardiovascular diseases were observed in countries with a higher API. Our results encourage the development and strengthening of alcohol-related policies worldwide.

IMPACT AND IMPLICATIONS

We first developed an alcohol preparedness index, an instrument to assess the existence of alcohol-related public policies for each country. We then evaluated the long-term association of the country's alcohol preparedness index in 2010 with the burden of chronic liver disease, hepatocellular carcinoma, other neoplasms, and cardiovascular disease. The strengthening of alcohol-related public health policies could impact long-term mortality rates from cardiovascular disease, neoplasms, and liver disease. These conditions are the main contributors to the global burden of disease related to alcohol use. Over time, this association has not only persisted but also grown stronger. Our results expand the preliminary evidence regarding the importance of public health policies in controlling alcohol-related health consequences.

摘要

背景与目的

酒精相关公共卫生政策(PHP)对疾病负担的长期影响尚不清楚。我们旨在评估酒精相关 PHPs 与酒精相关健康后果之间的关联。

方法

我们进行了一项包括 169 个国家的生态多国家研究。我们从 2010 年世界卫生组织全球酒精与健康信息系统中收集了酒精相关 PHPs 数据。2010-2019 年期间的酒精相关健康后果数据来自全球疾病负担数据库。我们将 PHPs 分为五个项目,包括低、中、强 PHP 建立的标准。我们使用多元对应分析(0 最低和 100 最高建立)来估计酒精准备指数(API)。我们使用具有泊松家族分布的调整多层广义线性模型根据 API 估计结局的发病率比值比(IRR)。

结果

169 个国家的 API 中位数为 54 [IQR 34.9-76.8]。API 与酒精使用障碍(AUD)患病率呈负相关(IRR 0.13;95%CI 0.03-0.60;p = 0.010),酒精相关性肝病(ALD)死亡率(IRR 0.14;95%CI 0.03-0.79;p = 0.025),恶性肿瘤死亡率(IRR 0.09;95%CI 0.02-0.40;p = 0.002),酒精相关性肝细胞癌(HCC)(IRR 0.13;95%CI 0.02-0.65;p = 0.014)和心血管疾病(IRR 0.09;95%CI 0.02-0.41;p = 0.002)。在美洲、非洲和欧洲观察到最高的关联。这些关联随着时间的推移而增强,AUD 患病率在基线 API 评估后 2 年内显著降低,而 ALD 死亡率和酒精相关性 HCC 发病率分别在基线 API 评估后 4 年和 8 年下降(p<0.05)。

结论

API 是量化酒精相关 PHP 建立稳健性的有用工具。在 API 较高的国家,观察到 AUD 患病率较低,与 ALD、恶性肿瘤、酒精相关性 HCC 和心血管疾病相关的死亡率较低。我们的结果鼓励在全球范围内制定和加强与酒精相关的政策。

影响和意义

我们首先开发了一个酒精准备指数,这是一种用于评估每个国家是否存在酒精相关公共政策的工具。然后,我们评估了 2010 年该国酒精准备指数与慢性肝病、肝细胞癌、其他肿瘤和心血管疾病负担之间的长期关联。酒精相关公共卫生政策的加强可能会影响心血管疾病、肿瘤和肝病的长期死亡率。这些情况是与酒精使用相关的全球疾病负担的主要原因。随着时间的推移,这种关联不仅持续存在,而且还变得更加强烈。我们的结果扩展了关于公共卫生政策在控制酒精相关健康后果方面重要性的初步证据。

相似文献

1
Association between public health policies on alcohol and worldwide cancer, liver disease and cardiovascular disease outcomes.公共卫生政策对酒精与全球癌症、肝脏疾病和心血管疾病结局的关联。
J Hepatol. 2024 Mar;80(3):409-418. doi: 10.1016/j.jhep.2023.11.006. Epub 2023 Nov 21.
2
Impact of Public Health Policies on Alcohol-Associated Liver Disease in Latin America: An Ecological Multinational Study.公共卫生政策对拉丁美洲酒精性肝病的影响:一项多国生态研究
Hepatology. 2021 Nov;74(5):2478-2490. doi: 10.1002/hep.32016. Epub 2021 Aug 22.
3
Global epidemiology of alcohol-related liver disease, liver cancer, and alcohol use disorder, 2000-2021.2000 - 2021年酒精性肝病、肝癌及酒精使用障碍的全球流行病学
Clin Mol Hepatol. 2025 Apr;31(2):525-547. doi: 10.3350/cmh.2024.0835. Epub 2025 Jan 9.
4
Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.在澳大利亚新南威尔士州直接作用抗病毒治疗时代,丙型肝炎病毒相关肝病负担下降。
J Hepatol. 2019 Aug;71(2):281-288. doi: 10.1016/j.jhep.2019.04.014. Epub 2019 May 10.
5
Socio-economic association of alcohol use disorder and cardiovascular and alcohol-associated liver disease from 2010 to 2019.2010 年至 2019 年期间,酒精使用障碍与心血管疾病和酒精相关肝病的社会经济关联。
Aliment Pharmacol Ther. 2024 Aug;60(3):340-349. doi: 10.1111/apt.18095. Epub 2024 May 29.
6
Associations Between Alcohol Use and Liver-Related Outcomes in a Large National Cohort of Patients With Cirrhosis.酒精使用与大规模全国肝硬化患者队列中肝脏相关结局的相关性研究。
Hepatol Commun. 2021 Dec;5(12):2080-2095. doi: 10.1002/hep4.1776. Epub 2021 Oct 3.
7
Alcoholic liver disease confers a worse prognosis than HCV infection and non-alcoholic fatty liver disease among patients with cirrhosis: An observational study.一项观察性研究表明,在肝硬化患者中,酒精性肝病的预后比丙型肝炎病毒感染和非酒精性脂肪性肝病更差。
PLoS One. 2017 Oct 27;12(10):e0186715. doi: 10.1371/journal.pone.0186715. eCollection 2017.
8
Alcohol use and hepatocellular carcinoma risk in patients with alcohol-related cirrhosis.酒精相关肝硬化患者的饮酒与肝细胞癌风险。
Scand J Gastroenterol. 2023 Jul-Dec;58(11):1321-1327. doi: 10.1080/00365521.2023.2220856. Epub 2023 Jun 8.
9
Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis.估算酒精性肝硬化患者肝细胞癌的发病率。
J Hepatol. 2018 Dec;69(6):1274-1283. doi: 10.1016/j.jhep.2018.07.022. Epub 2018 Aug 6.
10
Alcohol use disorder and the liver.酒精使用障碍与肝脏。
Addiction. 2021 May;116(5):1270-1278. doi: 10.1111/add.15204. Epub 2020 Aug 21.

引用本文的文献

1
National, regional, and global statistics on alcohol consumption and associated burden of disease 2000-20: a modelling study and comparative risk assessment.2000 - 2020年酒精消费及相关疾病负担的国家、区域和全球统计数据:一项建模研究和比较风险评估
Lancet Public Health. 2025 Sep;10(9):e751-e761. doi: 10.1016/S2468-2667(25)00174-4.
2
Global trends in the burden of alcohol use disorders in the working-age population from 1990 to 2021 and projections for the next 20 years.1990年至2021年工作年龄人口酒精使用障碍负担的全球趋势及未来20年预测。
Front Public Health. 2025 Jul 28;13:1616343. doi: 10.3389/fpubh.2025.1616343. eCollection 2025.
3
The Impact of Federal and State Laws on Cardiovascular Risk.
联邦和州法律对心血管风险的影响。
Curr Cardiol Rep. 2025 Aug 7;27(1):121. doi: 10.1007/s11886-025-02277-w.
4
Global, Regional, and National Burden of Pharyngeal Cancer and Projections to 2050 in 185 Countries: A Population-Based Systematic Analysis of GLOBOCAN 2022.185个国家咽癌的全球、区域和国家负担以及到2050年的预测:基于全球疾病负担研究(GLOBOCAN)2022的人群系统分析
J Korean Med Sci. 2025 Aug 4;40(30):e177. doi: 10.3346/jkms.2025.40.e177.
5
The Impact of Dietary Habits and Nutrition Knowledge on Harmful Alcohol Use and Nicotine Dependence Among Medical Students: A Single-Center, Cross-Sectional Study.饮食习惯和营养知识对医学生有害饮酒及尼古丁依赖的影响:一项单中心横断面研究
Nutrients. 2025 May 24;17(11):1788. doi: 10.3390/nu17111788.
6
Subgroups of Steatotic Liver Disease Have Distinct Clinical Phenotypes.脂肪性肝病亚组具有不同的临床表型。
J Clin Exp Hepatol. 2025 Sep-Oct;15(5):102587. doi: 10.1016/j.jceh.2025.102587. Epub 2025 Apr 30.
7
Public health policies to prevent alcohol-related liver disease.预防酒精性肝病的公共卫生政策。
Nat Rev Gastroenterol Hepatol. 2025 Jun 4. doi: 10.1038/s41575-025-01084-6.
8
Geographic diversity of human liver cancers mirrors global social inequalities.人类肝癌的地理多样性反映了全球社会不平等现象。
Front Oncol. 2025 May 16;15:1565692. doi: 10.3389/fonc.2025.1565692. eCollection 2025.
9
Noninvasive pathway for stratifying fibrosis in suspected metabolic dysfunction and alcohol-associated liver disease (MetALD).疑似代谢功能障碍和酒精相关性肝病(MetALD)中纤维化分层的非侵入性途径。
Hepatol Commun. 2025 May 16;9(6). doi: 10.1097/HC9.0000000000000718. eCollection 2025 Jun 1.
10
Letter: Addressing the Growing Disparities in Alcohol-Associated Liver Disease-A Call for Equitable Healthcare Strategies: Authors' Reply.信函:应对酒精性肝病日益扩大的差距——呼吁公平的医疗保健策略:作者回复
Aliment Pharmacol Ther. 2025 Jun;61(11):1836-1837. doi: 10.1111/apt.70158. Epub 2025 Apr 22.